Back
Bicara Therapeutics 10K Form
Buy
62
BCAX
Bicara Therapeutics
Last Price:
$13.41
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BCAX News And Ratings
See the #1 stock for the next 7 days that we like better than BCAX
BCAX Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $-3.80 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.20230 |
---|---|
Net Income (TTM): | $-64.8M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Bicara Therapeutics Earnings Forecast
Key Bicara Therapeutics Financial Ratios
-
Per Share Earnings over the last 2 years have been positive in 0 years.
Bicara Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | BCAX |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
BCAX Technical Analysis vs Fundamental Analysis
Buy
62
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy or a Sell?
-
Bicara Therapeutics stock is rated a BuyThe current Bicara Therapeutics [BCAX] share price is $13.40. The Score for BCAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.